Image For Activity Cover
Volume 48, Issue 3 September 2024 JVU 483-169 | Veins in the Lateral Fascial Compartment of the Calf
Volume 48, Issue 3 September 2024 JVU 483-169 | Veins in the Lateral Fascial Compartment of the Calf
September 2024 Journal for Vascular Ultrasound
J7051A-24-P

The September 2024 issue of the Journal for Vascular Ultrasound (JVU) includes two original research articles, three case reports, one case series, one technical note and one images in vascular ultrasound. The first original research article reports on vascular aging entails arterial dilatation and stiffness. The second research article reviews the relationship between diameter and pelvic reflux (1 AMA PRA Category 1 Credit ™). The first case report reviews dislodged thrombus following post-operative compression. The second case report includes the indirect diagnosis of innominate arterial occlusive disease with duplex ultrasound (0.5 AMA PRA Category 1 Credit ™). The third case reports on adventitial cystic disease followed by surgical repair (0.5 AMA PRA Category 1 Credit ™). The case series reports on the sonographic findings related to veins in the lateral compartment of the calf (0.5 AMA PRA Category 1 Credit ™). The images in vascular ultrasound reports on a radial artery pseudoaneurysm with a thrill and the technical note reviews the sonographic appearance of a Hemodialysis Reliable Outflow Graft (HeRO Graft) [0.5 AMA PRA Category 1 Credit ™].
.

LEARNING OBJECTIVES
After reading and studying the papers used for CME in the September 2024 Issue of the Journal for Vascular Ultrasound, participants will be able to:

1. List chronic symptoms associated with pelvic congestion syndrome.
2. List factors caused by pelvic congestion syndrome.
3. List the treatment options for refluxing and varicose veins.
4. State a neurological symptom lasting greater than 24 hours.
5. Describe the anatomical characteristics of the small saphenous vein on diagnostic ultrasound.
6. State the location of the persistent lateral marginal vein.
7. Describe the ultrasonic features of the interfacial vein in the longitudinal view.
8. State the imaging modalities used for suspected innominate artery occlusion prior to surgical intervention.
9. Describe the Doppler waveform characteristics of a more proximal high-grade stenosis or occlusion.
10. Explain the three levels of ischemia associated with innominate artery occlusive disease.
11. Describe the sonographic appearance of a cystic structure.

TARGET AUDIENCE
Physician, Vascular Technologist and Sonographer members of SVU should find participating in this educational activity valuable.

ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Penn State College of Medicine and the Society for Vascular Ultrasound. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Penn State College of Medicine designates this Enduring Material activity for a maximum of 1 AMA PRA Category 1 Credit ™ per article. Physicians should claim only the credits commensurate with the extent of their participation in the activity.

• Relationship Between Diameter and Pelvic Vein Reflux

Penn State College of Medicine designates this Enduring Material activity for a maximum of .5 AMA PRA Category 1 Credit ™ per article. Physicians should claim only the credits commensurate with the extent of their participation in the activity.

• Sonographic Appearance of a Hemodialysis Reliable Outflow Graft (HeRO Graft)
• Indirect Duplex Ultrasound Diagnosis of Innominate Artery Occlusive Disease
• Duplex Study of Right Popliteal Artery Revealed Adventitial Cystic Disease Followed by Surgical Repair
• Veins in the Lateral Fascial Compartment of the Calf

CREDIT AVAILABILITY
Activity release date: September 1, 2024
Expiration date: August 31, 2027

METHOD OF PARTICIPATION
This Enduring Material activity is available online at www.svu.org. To receive credit, participants must read the CME articles, including the learning objectives and disclosure statements, as well as the full content of each of these articles, and then complete the post test and evaluation form. Upon successful completion of the post test (80% correct) and evaluation form, a CME certificate of participation will be awarded automatically. The certificate may be printed directly from the website.

DISCLOSURE
Penn State College of Medicine is committed to offering CME activities that promote improvements or quality in health care and are developed free of the control of ineligible companies (formerly known as a commercial interests). Reasonable efforts have been taken to ensure that our activities are balanced, independent, objective, scientific, and in compliance with regulatory requirements. All authors have disclosed all relevant financial relationships with ineligible companies, and Penn State has a process in place to mitigate any conflict of interest. Disclosure of a relationship is not intended to suggest or condone bias in an article but is made to provide participants with information that might be of potential importance to their evaluation of an article.

Devices or drugs that are still undergoing clinical trials should not be portrayed as standard, accepted therapy. Please consult full prescribing information before using any product mentioned in this activity. If using products in an investigational, off-label manner, it is the responsibility of the prescribing physician to monitor the medical literature to determine recommended dosages and uses of the drugs.

The information presented at this CME activity represents the views and opinions of the individual authors, and does not constitute the opinion or endorsement of, or promotion by, Penn State College of Medicine. Each participant must use his/her personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

All relevant relationships have been mitigated. The following disclosures were made:

David Dawson, MD RPVI RVT FSVU -- Nothing to Disclose
Editor-in-Chief, JVU
University of Washington School of Medicine
Seattle, WA

Sandra Yesenko, MHS DHSc RVT RDMS FSVU -- Nothing to Disclose
Associate Editor for Education, JVU
Cleveland Clinic
Westlake, OH

Sandra Katanick, FSVU -- Nothing to Disclose
Managing Editor, JVU
Hollywood, FL

AUTHOR DISCLOSURE OF RELATIONSHIPS (CONFLICT OF INTEREST)

 

Fanilda Souto Barros, MD – Nothing to disclose                                                   Erika Carrion, RVT RDMS RDCS – Nothing to disclose

Jillian Clarke – Nothing to disclose                                                                        Joana Storina Pereira Costa, MD – Nothing to disclose

Patrick Kim, AS – Nothing to disclose                                                                   Gaorui Liu, DMU – Nothing to disclose               

Chancy Lim – Nothing to disclose                                                                         Irwin Mohan, MD MBBS – Nothing to disclose               

                                                                                               

 

 

Penn State Continuing Education staff involved in the planning of this activity have no financial relationships with any ineligible companies relevant to this activity.

 

Speakers/Authors are required to inform the activity audience when they are discussing/describing off-label or investigational uses of devices or drugs.

Summary
Availability: On-Demand
Expires on Aug 31, 2027
Cost: Member: $0.00
Non-Member: $20.00
Credit Offered:
0.5 AMA-PRA Category 1 Credit
0.5 SVU-CME Credit
Recommended
Powered By